Matthew Merriman, - Medicare Emergency Medicine in Apo, AE

Matthew Merriman, is a medicare enrolled "Emergency Medicine" physician in Apo, Armed Forces Europe. His current practice location is 57 Rqs, Unit 6117, Apo, Armed Forces Europe. You can reach out to his office (for appointments etc.) via phone at (314) 632-1957.

Matthew Merriman is licensed to practice in California (license number A155174) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1528485844.

Contact Information

Matthew Merriman,
57 Rqs, Unit 6117,
Apo, AE 09604-6117
(314) 632-1957
Not Available



Physician's Profile

Full NameMatthew Merriman
GenderMale
SpecialityEmergency Medicine
Location57 Rqs, Apo, Armed Forces Europe
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1528485844
  • Provider Enumeration Date: 03/25/2014
  • Last Update Date: 08/09/2021
  Medicare PECOS Information:
  • PECOS PAC ID: 5496048910
  • Enrollment ID: I20180915000024

Medical Identifiers

Medical identifiers for Matthew Merriman such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1528485844NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207P00000XEmergency Medicine A155174 (California)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Matthew Merriman allows following entities to bill medicare on his behalf.
Entity NameNorthbay Healthcare Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1821147786
PECOS PAC ID: 0042122244
Enrollment ID: O20031105000409

News Archive

Alcon concludes 'proof of concept' clinical trial of NovaBay's Aganocide for viral conjunctivitis treatment

NovaBay Pharmaceuticals, Inc. announced today that its development partner, Alcon Research, Ltd., has concluded its proof of concept clinical trial of NovaBay's patented lead Aganocide compound, NVC-422 for the treatment of viral conjunctivitis a highly contagious eye infection for which there are currently no marketed products.

Scripps Florida receives NIH grant to create novel HIV inhibitors

A Scripps Florida team has been awarded nearly $1.5 million by the National Institutes of Health to identify and develop novel potent inhibitors of the human immunodeficiency virus (HIV), the cause of AIDS.

Eosinophilic esophagitis gene discovery

Researchers at Cincinnati Children's Hospital Medical Center have discovered the first gene associated with eosinophilic esophagitis, one of a number of eosinophil-related diseases in which the body produces abnormally large amounts of white blood cells that can lead to allergy related illnesses.

Potential new drug to treat common inherited kidney disease

Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease - although it will be a few years before it becomes available for clinical testing. The findings resulted from a collaboration between UCSB and a biotech firm based in Indiana. The study is published in this week's Journal of the American Society of Nephrology.

PPMD to fund two promising research initiatives in Duchenne muscular dystrophy

Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today that PPMD will be funding two critical, promising research initiatives in Duchenne.

Read more Medical News

› Verified 8 days ago

Entity NameSolano Gateway Medical Group, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1952344293
PECOS PAC ID: 5496725418
Enrollment ID: O20040916001355

News Archive

Alcon concludes 'proof of concept' clinical trial of NovaBay's Aganocide for viral conjunctivitis treatment

NovaBay Pharmaceuticals, Inc. announced today that its development partner, Alcon Research, Ltd., has concluded its proof of concept clinical trial of NovaBay's patented lead Aganocide compound, NVC-422 for the treatment of viral conjunctivitis a highly contagious eye infection for which there are currently no marketed products.

Scripps Florida receives NIH grant to create novel HIV inhibitors

A Scripps Florida team has been awarded nearly $1.5 million by the National Institutes of Health to identify and develop novel potent inhibitors of the human immunodeficiency virus (HIV), the cause of AIDS.

Eosinophilic esophagitis gene discovery

Researchers at Cincinnati Children's Hospital Medical Center have discovered the first gene associated with eosinophilic esophagitis, one of a number of eosinophil-related diseases in which the body produces abnormally large amounts of white blood cells that can lead to allergy related illnesses.

Potential new drug to treat common inherited kidney disease

Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease - although it will be a few years before it becomes available for clinical testing. The findings resulted from a collaboration between UCSB and a biotech firm based in Indiana. The study is published in this week's Journal of the American Society of Nephrology.

PPMD to fund two promising research initiatives in Duchenne muscular dystrophy

Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today that PPMD will be funding two critical, promising research initiatives in Duchenne.

Read more Medical News

› Verified 8 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Matthew Merriman is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Matthew Merriman,
Psc 103 Box 5415,
Apo, AE 09603-0055

Ph: () -
Matthew Merriman,
57 Rqs, Unit 6117,
Apo, AE 09604-6117

Ph: (314) 632-1957

News Archive

Alcon concludes 'proof of concept' clinical trial of NovaBay's Aganocide for viral conjunctivitis treatment

NovaBay Pharmaceuticals, Inc. announced today that its development partner, Alcon Research, Ltd., has concluded its proof of concept clinical trial of NovaBay's patented lead Aganocide compound, NVC-422 for the treatment of viral conjunctivitis a highly contagious eye infection for which there are currently no marketed products.

Scripps Florida receives NIH grant to create novel HIV inhibitors

A Scripps Florida team has been awarded nearly $1.5 million by the National Institutes of Health to identify and develop novel potent inhibitors of the human immunodeficiency virus (HIV), the cause of AIDS.

Eosinophilic esophagitis gene discovery

Researchers at Cincinnati Children's Hospital Medical Center have discovered the first gene associated with eosinophilic esophagitis, one of a number of eosinophil-related diseases in which the body produces abnormally large amounts of white blood cells that can lead to allergy related illnesses.

Potential new drug to treat common inherited kidney disease

Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is effective in treating a very common kidney disease - although it will be a few years before it becomes available for clinical testing. The findings resulted from a collaboration between UCSB and a biotech firm based in Indiana. The study is published in this week's Journal of the American Society of Nephrology.

PPMD to fund two promising research initiatives in Duchenne muscular dystrophy

Patricia A. Furlong, Founding President and CEO of Parent Project Muscular Dystrophy (PPMD), the largest non-profit organization in the United States focused on finding a cure for Duchenne muscular dystrophy (Duchenne), announced today that PPMD will be funding two critical, promising research initiatives in Duchenne.

Read more News

› Verified 8 days ago


Emergency Medicine Doctors in Apo, AE

Dr. Ana Paola Geluso, MD, MBA
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180
Phone: 314-590-6322    
Dr. Peter Jon Benson, MD
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: Hq Soceur, Unit 30400, Apo, AE 09131
Phone: 011-497-116807620    
Robert E Thaxton, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: Unit 33100, Apo, AE 09180
Phone: 314-590-8072    
Dr. Terata Ann Kanu, M.D.
Emergency Medicine
Medicare: Accepting Medicare Assignments
Practice Location: 18th Medical Group, Unit 5142, Apo, AE 96368
Phone: 315-630-4315    
Dr. Danielle J Wilhelm, M.D.
Emergency Medicine
Medicare: Not Enrolled in Medicare
Practice Location: Landstuhl Regional Medical Center, Apo, AE 09180
Phone: 004-967-3194645762    
Rush M Twilley, M.D.
Emergency Medicine
Medicare: Medicare Enrolled
Practice Location: Cmr 427, Box 4226, Apo, AE 09630
Phone: 328-556-9239    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2022 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.